FFA
PTGX icon

Farther Finance Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Farther Finance Advisors’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Buy
333
+36
+12% +$3.19K ﹤0.01% 3257
2025
Q4 		$25.9K Buy
297
+156
+111% +$12.8K ﹤0.01% 3261
2025
Q3 		$9.37K Buy
141
+48
+52% +$2.73K ﹤0.01% 3468
2025
Q2 		$5.14K Sell
93
-296
-76% -$14.2K ﹤0.01% 3346
2025
Q1 		$18.2K Buy
389
+345
+784% +$14.5K ﹤0.01% 2426
2024
Q4 		$1.7K Hold
44
– – ﹤0.01% 3058
2024
Q3 		$1.98K Sell
44
-1
-2% -$40 ﹤0.01% 2997
2024
Q2 		$1.58K Buy
45
+5
+13% +$146 ﹤0.01% 2885
2024
Q1 		$1.13K Hold
40
– – ﹤0.01% 2723
2023
Q4 		$917 Buy
+40
New +$700 ﹤0.01% 2771

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return